Veritas Signs MOU with the Chamber of Commerce, Industry, Services and Tourism Brazil & Puerto Rico
August 13, 2018 09:00 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company) is pleased to announce that it has entered...
Frankfurt’s Clearstream Banking Lifts Settlement Restrictions on Securities Active in Medical Cannabis
August 08, 2018 03:30 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Clearstream...
Veritas Pharma Signs IP Agreement with UK’s First Medicinal Cannabis Investment Fund
July 17, 2018 16:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that it has signed an...
Veritas Appoints Mr. Filios Theodorou as Its Agent for Cyprus and SEMEA Countries
June 25, 2018 03:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that Mr. Filios...
Veritas Pharma Has Retained Cannabis Branding Firm for Design of Label and Packaging
May 15, 2018 17:06 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce with the dealer licence...
Veritas Pharma Provides Comment on Canadian Senate Recommendation for a One-Year Deferment Legalizing Cannabis
May 10, 2018 03:10 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, May 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) provides the following statement to the...
Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics
March 21, 2018 03:15 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the Company has...
Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1
February 20, 2018 03:10 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the Company and its...
Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders
January 04, 2018 17:24 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide an update to its...
Veritas Pharma Subsidiary Receives Health Canada Dealer Licence
December 28, 2017 03:05 ET
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that Health Canada has issued its...